全文获取类型
收费全文 | 2515757篇 |
免费 | 178310篇 |
国内免费 | 3827篇 |
专业分类
耳鼻咽喉 | 34211篇 |
儿科学 | 80581篇 |
妇产科学 | 67110篇 |
基础医学 | 371735篇 |
口腔科学 | 69594篇 |
临床医学 | 222339篇 |
内科学 | 492948篇 |
皮肤病学 | 56882篇 |
神经病学 | 199023篇 |
特种医学 | 91996篇 |
外国民族医学 | 517篇 |
外科学 | 372690篇 |
综合类 | 48356篇 |
现状与发展 | 12篇 |
一般理论 | 879篇 |
预防医学 | 201717篇 |
眼科学 | 58451篇 |
药学 | 187654篇 |
11篇 | |
中国医学 | 5156篇 |
肿瘤学 | 136032篇 |
出版年
2021年 | 22502篇 |
2019年 | 23098篇 |
2018年 | 32048篇 |
2017年 | 23577篇 |
2016年 | 26022篇 |
2015年 | 29201篇 |
2014年 | 40705篇 |
2013年 | 60700篇 |
2012年 | 85410篇 |
2011年 | 90473篇 |
2010年 | 52923篇 |
2009年 | 49372篇 |
2008年 | 83448篇 |
2007年 | 88778篇 |
2006年 | 89290篇 |
2005年 | 86399篇 |
2004年 | 82297篇 |
2003年 | 78946篇 |
2002年 | 76336篇 |
2001年 | 112135篇 |
2000年 | 115009篇 |
1999年 | 96477篇 |
1998年 | 27980篇 |
1997年 | 24376篇 |
1996年 | 24703篇 |
1995年 | 23283篇 |
1994年 | 21359篇 |
1993年 | 20145篇 |
1992年 | 73724篇 |
1991年 | 71765篇 |
1990年 | 70066篇 |
1989年 | 67185篇 |
1988年 | 61754篇 |
1987年 | 60484篇 |
1986年 | 56591篇 |
1985年 | 54297篇 |
1984年 | 40294篇 |
1983年 | 34284篇 |
1982年 | 20409篇 |
1979年 | 37023篇 |
1978年 | 26432篇 |
1977年 | 21961篇 |
1976年 | 21036篇 |
1975年 | 22638篇 |
1974年 | 27196篇 |
1973年 | 25911篇 |
1972年 | 24238篇 |
1971年 | 23044篇 |
1970年 | 21224篇 |
1969年 | 20332篇 |
排序方式: 共有10000条查询结果,搜索用时 11 毫秒
31.
32.
33.
34.
35.
Dolores Herreros Mariano García-Arranz Isabel Pascual Damián García-Olmo 《Experimental dermatology》2006,15(6):482-482
Purpose: To evaluate all consecutive patients treated with infliximab for hidradenitis suppurativa (HS).
Patients and methods: Within 1 year, all consecutive patients seen in our department for HS (1) resistant to usual medical therapies (2) which could not be easily cured by surgery (3) not treated with new medication within 2 months before inclusion were treated intravenously with infliximab (5 mg/kg) without corticosteroids premedication. Four infusions were planned (week 0, week 2, week 6 and week 10) before the interruption of therapy and follow-up. Clinical activity of HS and quality of life of the patients were assessed immediately before the first, the third and the fourth infusions of infliximab.
Results: Seven patients were included. Five completed the four infusions. Two patients received only three infusions because of severe side effects. The Sartorius score moderately improved with infliximab (mean score at week 0: 94 ± 39, at week 6: 71 ± 38 and at week 10: 83 ± 48). At week 6, patients judged the efficacy of therapy as marked ( n = 1), moderate ( n = 4) or null ( n = 2). At week 10, five patients were evaluated and judged this efficacy as marked ( n = 2), moderate ( n = 2) or null ( n = 1). The mean Skindex-29 score varied from 22 ± 11 (E: 25 ± 9, S: 13 ± 5, F: 28 ± 12) at week 0 to 18 ± 10 (E: 22 ± 8, S: 12 ± 8, F: 22 ± 12) at week 10.
Conclusion: The efficacy of infliximab in severe HS is partial. More experience is needed before finding a place for infliximab in the therapeutic armamentarium for HS. 相似文献
Patients and methods: Within 1 year, all consecutive patients seen in our department for HS (1) resistant to usual medical therapies (2) which could not be easily cured by surgery (3) not treated with new medication within 2 months before inclusion were treated intravenously with infliximab (5 mg/kg) without corticosteroids premedication. Four infusions were planned (week 0, week 2, week 6 and week 10) before the interruption of therapy and follow-up. Clinical activity of HS and quality of life of the patients were assessed immediately before the first, the third and the fourth infusions of infliximab.
Results: Seven patients were included. Five completed the four infusions. Two patients received only three infusions because of severe side effects. The Sartorius score moderately improved with infliximab (mean score at week 0: 94 ± 39, at week 6: 71 ± 38 and at week 10: 83 ± 48). At week 6, patients judged the efficacy of therapy as marked ( n = 1), moderate ( n = 4) or null ( n = 2). At week 10, five patients were evaluated and judged this efficacy as marked ( n = 2), moderate ( n = 2) or null ( n = 1). The mean Skindex-29 score varied from 22 ± 11 (E: 25 ± 9, S: 13 ± 5, F: 28 ± 12) at week 0 to 18 ± 10 (E: 22 ± 8, S: 12 ± 8, F: 22 ± 12) at week 10.
Conclusion: The efficacy of infliximab in severe HS is partial. More experience is needed before finding a place for infliximab in the therapeutic armamentarium for HS. 相似文献
36.
Effects of poor glucose handling on arterial stiffness and left ventricular mass in normal children.
AIM: Cardiovascular risk factors can be present in children and young adults. We previously found abnormal microvascular function in children who had glucose intolerance and insulin resistance. The aim of the present study was to investigate whether they also have abnormalities in left ventricular mass (LVM) and arterial stiffness. METHODS: We measured heart dimensions and LVM using echocardiography, and arterial stiffness using pulse wave analysis in 23 children with good glucose handling (postfeeding glucose: 3.9 to 5 mmol/L) and 21 with poor glucose handling (7.7 to 11.4 mmol/L). RESULTS: The time to pulse reflection was slightly shorter in the poorer glucose handlers (mean+/-SD: 143+/-10 vs 153+/-20 ms, P=0.04), suggestive of increased arterial stiffness. Also in this group, there were significant relationships between intraventricular septal thickness, blood pressure and body mass index, but not in the normal glucose handlers. CONCLUSIONS: We have found that normal children who are in the lowest quintile of glucose tolerance in comparison with their peers are exhibiting the first signs of arterial stiffening. In addition, we have seen the beginnings of a relationship between blood pressure, body mass index and left ventricular enlargement in this group. While these changes may not yet be clinically significant, their emergence might be further evidence of early predisposition to cardiovascular disease. 相似文献
37.
R C Pattinson L C Snyman A P Macdonald 《Suid-Afrikaanse tydskrif vir geneeskunde》2006,96(11):1191-1194
AIM: To evaluate whether the introduction of a strict protocol approach based on the systemic evaluation of critically ill pregnant women with complications of abortion affected outcome. SETTING: Indigent South Africans managed in the regional and tertiary hospitals of the Pretoria Academic Complex. METHOD: Since 1997 a standard definition of severe acute maternal morbidity (SAMM) has been used in the Pretoria Academic Complex. All cases of SAMM and maternal deaths were entered on the Maternal Morbidity and Mortality Audit System programme. A comparison of outcome of severely ill women who had complications of abortion was made between 1997-1998 (original protocol) and 2002-2004 (strict protocol). OUTCOME MEASURES: The mortality index and prevalence of organ system failure or dysfunction. RESULTS: In 1997-1998 there were 43 women with SAMM who survived and a further 10 maternal deaths due to complications of abortion, compared with 107 women with SAMM and 7 maternal deaths during 2002-2004. The mortality index declined from 18.9% in 1997-1998 to 6.1% in 2002-2004 (p = 0.02, odds ratio 0.28, 95% confidence limits 0.10 - 0.79). Significantly more women had hypovolaemic shock in 2002-2004 compared with 1997-1998 (54.4% v. 35.8%, p = 0.04), but fewer women had immune system failure including septic shock (18.4% v. 47.2%, p = 0.0002) and metabolic dysfunction (0 v. 5.7%, p = 0.03) and there was a trend to less renal failure (10.5% v. 22.6%, p = 0.06) and cardiac failure (4.4% v. 13.2%, p = 0.08). CONCLUSION: The strict protocol approach based on systemic evaluation in managing critically ill pregnant women with complications of abortion, coupled with an intensive, regular feedback mechanism, has been associated with a reduction in the mortality index. 相似文献
38.
39.
40.
A M Carella 《Leukemia》2003,17(6):1199-1200